High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer

• Published in: Applied immunohistochemistry & molecular morphology Vol. 31; no. 2; p. 77
• Main Authors: Weidemann, Sören, Gorbokon, Natalia, Lennartz, Maximilian, Hube-Magg, Claudia, Fraune, Christoph, Bernreuther, Christian, Clauditz, Till S, Jacobsen, Frank, Jansen, Kristina, Schmalfeldt, Barbara, Wölber, Linn, Paluchowski, Peter, Berkes, Enikö, Heilenkötter, Uwe, Sauter, Guido, Uhlig, Ria, Wilczak, Waldemar, Steurer, Stefan, Simon, Ronald, Krech, Till, Marx, Andreas, Burandt, Eike, Lebok, Patrick
• Format: Journal Article
• Language: English
• Published: United States 01.02.2023
• Subjects: Biomarkers, Tumor - metabolism; Female; GPI-Linked Proteins - metabolism; Humans; Immunohistochemistry; Lymphatic Metastasis; Mesothelin; Ovarian Neoplasms - pathology
• ISSN: 1533-4058
• DOI: 10.1097/PAI.0000000000001097

To study the extent of heterogeneity of mesothelin overexpression in primary ovarian cancers and their peritoneal and lymph node metastases, a tissue microarray (TMA) was constructed from multiple sites of 220 ovarian cancers and analyzed by immunohistochemistry. One tissue core each was taken from up to 18 different tumor blocks per cancer, resulting in a total of 2460 tissue spots from 423 tumor sites (188 primary cancers, 162 peritoneal carcinosis, and 73 lymph node metastases). Positive mesothelin expression was found in 2041 of the 2342 (87%) arrayed tissue spots and in 372 of the 392 (95%) tumor sites that were interpretable for mesothelin immunohistochemistry. Intratumoral heterogeneity was found in 23% of 168 primary cancer sites interpretable for mesothelin and decreased to 12% in 154 peritoneal carcinosis and to 6% in 71 lymph node metastases ( P <0.0001). Heterogeneity between the primary tumor and matched peritoneal carcinosis was found in 16% of 102 cancers with interpretable mesothelin results. In these cancers, the mesothelin status switched from positive in the primary tumor to negative in the peritoneal carcinosis (3 cancers) in or vice versa (2 cancers), or a mixture of positive and negative peritoneal carcinoses was found (11 cancers). No such switch was seen between the mesothelin-interpretable primary tumors and their nodal metastases of 59 cancers, and only 1 mesothelin-positive tumor had a mixture of positive and negative lymph node metastases. In conclusion, mesothelin expression is frequent and highly homogeneous in ovarian cancer.